Host-directed therapy against mycobacterium tuberculosis infections with diabetes mellitus

Host-directed therapy against mycobacterium tuberculosis infections with diabetes mellitus

Tuberculosis (TB) is caused by the bacterial pathogen Mycobacterium tuberculosis (MTB) and is one of the principal reasons for mortality and morbidity worldwide. Currently, recommended anti-tuberculosis drugs include isoniazid, rifampicin, ethambutol, and pyrazinamide. TB treatment is lengthy and in...

Full description

Bibliographic Details
Main Authors: Li Zhao, Ke Fan, Xuezhi Sun, Wei Li, Fenfen Qin, Liwen Shi, Feng Gao, Chunlan Zheng
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Immunology
Subjects:
mycobacterium tuberculosis
diabetes mellitus
host-directed therapy
drug-resistance
immune
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1305325/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1305325/full

Similar Items